Shares of medical technology company CONMED CNMD.N down 1.7% at $36.78
Piper Sandler downgrades CNMD to "neutral" from "overweight" citing lack of near-term catalysts
Says ongoing concerns around AirSeal performance and execution missteps have weighed on the stock for nearly two years
Cuts PT to $39, which still implies an upside of 4.3% to stock's last close
All six brokerages covering CNMD rate stock "hold"; median PT is $43 - LSEG data
Including session's moves, CNMD down ~9.6% YTD